CFO Insights | KPMG | US

Healthcare and Life Sciences CFO Insights

CFO Insights

CFOs are leading the path for transformation.

CFOs are leading the path for transformation

THE CFO AGENDA

With a shift from volume to value, decreased margins, and portfolio rationalization, healthcare and life sciences CFOs must navigate a sea of change.  Learn how KPMG can assist CFOs improve operational effectiveness, implement strategic plans, drive profitable growth, and instate a governance model.

Value-based pricing in pharmaceuticals - hype or hope?

The industry is under the public and political microscope. Can VBP add the value that healthcare systems and patients are looking for?

 
Read more

Contact

Potential Tax Implications of Healthcare Reform

Reform legislation (if enacted) would near-certainly include tax law changes—changes that would affect individuals, the healthcare industry, and the business community at large.

 
Read more

Medicare Advantage Insight Study

Medicare Advantage may help health plans transition from volume to value.

 
Read more

MACRA: The final rule in brief

Understand the impact of the Medicare Access and CHIP Reauthorization Act.

 
Read more

Improving the Value of Divestitures

Reduce costs and improve value through strategic M&A transition management.

 
Read more

A Window to the Future

Global business services yield sustainable improvements and unlock value.

 
Read more

Connect with us

 

Request for proposal

 

Submit